Celsius Therapeutics
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $97M
Investors
- 11
About Celsius Therapeutics
Celsius Therapeutics, Inc.Founded in 2018 and headquartered in Cambridge, US, Celsius Therapeutics develops therapies targeting immune-mediated diseases. The company was recently acquired by AbbVie for USD 250 mn, enhancing its capacity to deliver advanced treatments.Celsius Therapeutics, now part of AbbVie, specializes in developing therapies for immune-mediated diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Their products employ genomic technologies to modulate immune responses, targeting specific pathways to improve patient outcomes.Celsius Therapeutics generates revenue through direct sales of its biologic therapies, primarily dispensed via healthcare providers and specialty pharmacies. The pricing reflects the advanced nature of the products, determined by development costs and therapeutic benefits.The recent acquisition by AbbVie aims to leverage the development of CEL383, targeting new treatment options for inflammatory bowel disease (IBD) patients. The company plans to expand its market presence and introduce innovative products designed to enhance treatment efficacy.
Who invested in Celsius Therapeutics
11 investors across 2 rounds
See all investors in Celsius Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celsius Therapeutics
Who invested in Celsius Therapeutics?
Celsius Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celsius Therapeutics raised?
Celsius Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Celsius Therapeutics last raise money?
Celsius Therapeutics's most recent round on record is a Series B, in Mar 2022.
What does Celsius Therapeutics do?
Celsius Therapeutics is a biotechnology company.
Where is Celsius Therapeutics headquartered?
Celsius Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Celsius Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celsius Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Celsius Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.